Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 1/2011

01-02-2011 | Introduction To Review Articles

Oral premalignant lesions

Author: Teruo Amagasa

Published in: International Journal of Clinical Oncology | Issue 1/2011

Login to get access

Excerpt

Oral cancer is the most common head and neck cancer, found in 270,000 patients annually worldwide [1]. The mortality rate due to cancer has continued to increase over the last 50 years in Japan. Within the last 25 years, carcinoma has become the leading cause of death in Japan, with the number of people dying from oral and pharyngeal carcinoma increasing approximately threefold [2]. While early detection and early treatment of oral cancer are important for improving the survival rate of patients, prevention of oral cancer will clearly contribute most to decreasing its death rate. …
Literature
1.
Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55:74–108CrossRef
2.
Health and Welfare Statistics Association (2009) Statistical abstracts on health and welfare in Japan
3.
Amagasa T, Yamashiro M, Ishikawa H (2006) Oral leukoplakia related malignant transformation. Oral Sci Int 3:45–55
4.
Kramer IRH, Lucas RB, Pindborg JJ et al (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539
5.
Pindborg JJ (1980) Oral cancer and precancer. John Wright & Sons Ltd, Bristol, pp 15–19
6.
Axell T, Holmstrup P, Kramer IRH et al (1984) International seminar in oral leukoplakia and associated lesions related tobacco habits. Commun Dent Epidermiol 12:145–154CrossRef
7.
Axell T, Pindborg JJ, Smith CJ et al (1996) Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21 1994. J Oral Pathol Med 25:49–54
8.
Pindborg JJ, Reichart PA, Smith CJ et al (1997) Histological typing of cancer and precancer of the oral mucosa, 2nd edn. Springer, Berlin
9.
Warnakulasuriya S, Johnson NW, van der Wall I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575–580CrossRefPubMed
10.
van der Wall I (2009) Potentially malignant disorders of the oral mucosa and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45:317–323CrossRef
11.
Warnakulasuriya S, Reibel J, Bouquot J et al (2008) Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 37:127–133CrossRefPubMed
12.
Pindborg JJ, Reibel J, Holmstrup P (1985) Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 14:698–708CrossRefPubMed
13.
Abbey L, Kaugars GE, Gunsolley JC et al (1995) Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol 80:188–191
14.
Karabulut A, Reibel J, Therkildsen MH et al (1995) Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 24:198–200CrossRefPubMed
15.
Barnes L, Eveson JW, Reichart P et al (eds) (2005) World Health Organization classification of tumours, pathology and genetics of head and neck tumours. IARC Press, Lyon pp 140–143, 163–175, 177–179
16.
Gale N, Kambic V, Michaels L et al (2000) The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions. Adv Anat Pathol 7:240–251CrossRefPubMed
17.
Hellquist H, Cardesa A, Gale N et al (1999) Criteria for grading in the Ljubljana classification of epithelial hyperplastic laryngeal lesions. A study by members of the Working Group on Epithelial Hyperplastic Laryngeal Lesions of the European Society of Pathology. Histopathology 34:226–233CrossRefPubMed
18.
Hellquist H, Lundgren J, Olofsson J (1982) Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords a follow-up study. Clin Otolaryngol 7:11–27CrossRefPubMed
19.
Kambic V, Gale N (1995) Epithelial hyperplastic lesions of the larynx. Elsevier, Amsterdam
20.
Amagasa T, Yokoo E, Sato K et al (1985) A study of the clinical characteristics and treatment of oral carcinoma in situ. Oral Surg Oral Med Oral Pathol 60:50–55CrossRefPubMed
21.
Silverman S Jr, Gorsky M, Lozada F (1984) Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 53:563–568CrossRefPubMed
22.
Sakr WA, Gale N, Gnepp DR et al (2009) Squamous intraepithelial neoplasia of the upper aerodigestive tract. In: Gnepp DR (ed) Diagnostic surgical pathology of the head and neck, 2nd edn. Saunders, Philadelphia
23.
Shimizu M, Nagata K, Yamaguchi H et al (2009) Squamous intraepithelial neoplasia of the esophagus: past, present, and future. J Gastroenterol 44:103–112CrossRefPubMed
24.
The Working Committee of New Histopathological Criteria for Borderline Malignancies of the Oral Mucosa, Japanese Society for Oral Pathology (2007) Oral CIS (JSOP) Catalog: histopathological variations. Sunashobo Publishing Co Ltd, Tokyo
Metadata
Title
Oral premalignant lesions
Author
Teruo Amagasa
Publication date
01-02-2011
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 1/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0158-2

Other articles of this Issue 1/2011

International Journal of Clinical Oncology 1/2011 Go to the issue

Original Article

Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy

Original Article

Impact of double-balloon rectal catheter use in external-beam radiotherapy for prostate cancer

Case Report

Primary intracranial leiomyosarcoma in an HIV-infected patient

Case Report

Gastrectomy and chemotherapy with S-1 for gastric cancer in a patient with acquired immunodeficiency syndrome

Review Article

Oral premalignant lesions: from the pathological viewpoint

Case Report

Leiomyosarcoma of the renal vein
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits